TrialNature2022
Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Rodabe N Amaria et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
191 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialNature2022
Rodabe N Amaria et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.